A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.

A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent ...

Hundreds of millions of people worldwide suffer from Type 2 diabetes, which can lead to kidney failure, blindness and ...

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Pegasys Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering The ...

A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to ...

Because of decades of high-stress and deficient healthcare, a 59-year-old in prison has a ‘geriatric morbidity’ equal to a 75 ...

The World Health Organization (WHO) is issuing, for the first time, recommendations on new near-point-of-care (NPOC) ...

A coroner has now issued a warning ...

At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches.

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...

The Standing Committee on National Health Services, Regulations and Coordination (NHSR&C) emphasised that diabetes, HIV, ...